Zhi-gang Zhuang

Shanghai Key Laboratory Of Maternal Fetal Medicine
Shanghai, 200092, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications

Precision treatment with artificial intelligence assisted subtyping enhances therapeutic efficacy in HR+/HER2- breast cancer: The LINUXtrial.

Precision treatment with artificial intelligence assisted subtyping enhances therapeutic efficacy in HR+/HER2- breast cancer: The LINUXtrial.

Journal: Cancer cell
Published: March 08, 2025

Intensive chemotherapy versus standard chemotherapy among patients with high risk, operable, triple negative breast cancer based on integrated mRNA-lncRNA signature (BCTOP-T-A01): randomised, multicentre, phase 3 trial.

Intensive chemotherapy versus standard chemotherapy among patients with high risk, operable, triple negative breast cancer based on integrated mRNA-lncRNA signature (BCTOP-T-A01): randomised, multicentre, phase 3 trial.

Journal: BMJ (Clinical research ed.)
Published: October 23, 2024

Anthracycline-free or short-term regimen as adjuvant chemotherapy for operable breast cancer: A phase III randomized non-inferiority trial.

Anthracycline-free or short-term regimen as adjuvant chemotherapy for operable breast cancer: A phase III randomized non-inferiority trial.

Journal: The Lancet regional health. Western Pacific
Published: February 07, 2021

Multiple cancer susceptible genes sequencing in BRCA-negative breast cancer with high hereditary risk.

Multiple cancer susceptible genes sequencing in BRCA-negative breast cancer with high hereditary risk.

Journal: Annals of translational medicine
Published: December 14, 2020

Dynamic Regulative Biomarker: Long Noncoding RNA (lncRNA) in Metastatic Breast Cancer.

Dynamic Regulative Biomarker: Long Noncoding RNA (lncRNA) in Metastatic Breast Cancer.

Journal: Clinical laboratory
Published: September 09, 2020

Effect of Adjuvant Paclitaxel and Carboplatin on Survival in Women With Triple-Negative Breast Cancer: A Phase 3 Randomized Clinical Trial.

Effect of Adjuvant Paclitaxel and Carboplatin on Survival in Women With Triple-Negative Breast Cancer: A Phase 3 Randomized Clinical Trial.

Journal: JAMA oncology
Published: August 14, 2020

A Novel lncRNA HOXC-AS3 Acts as a miR-3922-5p Sponge to Promote Breast Cancer Metastasis.

A Novel lncRNA HOXC-AS3 Acts as a miR-3922-5p Sponge to Promote Breast Cancer Metastasis.

Journal: Cancer investigation
Published: December 05, 2019

Concurrent neoadjuvant chemotherapy and estrogen deprivation in patients with estrogen receptor-positive, human epidermal growth factor receptor 2-negative breast cancer (CBCSG-036): A randomized, controlled, multicenter trial.

Concurrent neoadjuvant chemotherapy and estrogen deprivation in patients with estrogen receptor-positive, human epidermal growth factor receptor 2-negative breast cancer (CBCSG-036): A randomized, controlled, multicenter trial.

Journal: Cancer
Published: October 22, 2018

The spectrum of BRCA mutations and characteristics of BRCA-associated breast cancers in China: Screening of 2,991 patients and 1,043 controls by next-generation sequencing.

The spectrum of BRCA mutations and characteristics of BRCA-associated breast cancers in China: Screening of 2,991 patients and 1,043 controls by next-generation sequencing.

Journal: International journal of cancer
Published: November 11, 2016

Expression of CCL2 is significantly different in five breast cancer genotypes and predicts patient outcome.

Expression of CCL2 is significantly different in five breast cancer genotypes and predicts patient outcome.

Journal: International journal of clinical and experimental medicine
Published: March 29, 2015

Expression of aryl hydrocarbon receptor in relation to p53 status and clinicopathological parameters in breast cancer.

Expression of aryl hydrocarbon receptor in relation to p53 status and clinicopathological parameters in breast cancer.

Journal: International journal of clinical and experimental pathology
Published: June 09, 2014

Preoperative measurement of breast cancer overestimates tumor size compared to pathological measurement.

Preoperative measurement of breast cancer overestimates tumor size compared to pathological measurement.

Journal: PloS one
Published: September 23, 2013
Showing 1-12 of 12

Last Updated: 09/26/2026